Why Not Extend Endocrine Therapy for All Patients Who Are Tolerating?

Help Increase Patient Adherence to Extended Endocrine Therapy RecommendationsПодробнее

Exploring Extended Adjuvant Endocrine Therapy for HR+ Breast CancerПодробнее

Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapyПодробнее

Extended endocrine therapy for the treatment and prevention of breast cancer relapseПодробнее

Partnering to Provide Personalized Care: Patient Selection for Extended Endocrine TherapyПодробнее

Not All Women Who Are Clinically High-Risk Benefit from Extended Endocrine TherapyПодробнее

Standardizing Extended Endocrine Therapy RecommendationsПодробнее

Dr. Joseph Sparano on the Role of Endocrine Therapy in Breast CancerПодробнее

Breast Cancer: Extended Adjuvant Endocrine TherapyПодробнее

Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast CancerПодробнее

Dr. VK Gadi: Guideline Updates for Extended Endocrine Therapy Decision-MakingПодробнее

Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast CancerПодробнее

Duration of endocrine therapy in early breast cancerПодробнее

Consideration of Side Effects in Extended Endocrine Therapy Decision MakingПодробнее

Clinicopathologic Features DO NOT Predict Benefit from Extended Endocrine TherapyПодробнее

Breast Cancer Index, Extended Endocrine Therapy | Elizabeth Ott, PA | 2022 West Oncology APP UpdatesПодробнее

Combination treatments for premenopausal breast cancer: endocrine therapy and ovarian suppressionПодробнее

Dr. Graff on Extended Adjuvant Therapy in Early-Stage HR+ Breast CancerПодробнее

Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice GuidelinesПодробнее

Adjuvant endocrine therapy for breast cancer: optimal durations and regimensПодробнее